Deaun Gehring
Family Medicine · Denver, CONPI 1568477420
Payments from drug & device makers
Across 127 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$345
- Lilly USA, LLC$300
- Pfizer$225
- Novo Nordisk$198
- GSK$180
- Gilead$172
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 15 | $345 |
| Lilly USA, LLC | 15 | $300 |
| Pfizer | 11 | $225 |
| Novo Nordisk | 9 | $198 |
| GSK | 10 | $180 |
| Gilead | 6 | $172 |
| Bayer | 7 | $163 |
| Sanofi Pasteur Inc. | 5 | $128 |
| Medtronic | 4 | $100 |
| Eisai Inc. | 4 | $91 |
| Cranial Technologies, Inc | 5 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $74 |
| Hologic Sales And Service, LLC | 3 | $74 |
| Astellas Pharma US Inc | 3 | $72 |
| Inspire Medical Systems, Inc. | 1 | $67 |
| Merck | 4 | $67 |
| Stryker | 1 | $65 |
| Organon | 3 | $61 |
| Exact Sciences | 3 | $51 |
| AstraZeneca | 3 | $44 |
| Lucid Diagnostics Inc. | 1 | $33 |
| Amgen | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Boston Scientific | 1 | $27 |
| Abiomed | 1 | $26 |
| Echosens North America, Inc. | 1 | $26 |
| Abbott | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Sonex Health, Inc. | 1 | $12 |
How this compares
$2,829 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $31,558 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $3,363 |
| Levothyroxine Sodium | 54 | $1,979 |
| Atorvastatin Calcium | 125 | $893 |
| Omeprazole | 27 | $749 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $600 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $594 |
| Amlodipine Besylate | 68 | $509 |
| Lisinopril | 57 | $391 |
| Gabapentin | 23 | $367 |
| Losartan Potassium | 53 | $350 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 27 | $333 |
| Oxycodone Hcl | 12 | $309 |
| Metformin Hcl | 40 | $242 |
| Metoprolol Succinate | 24 | $238 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $198 | $31,55820 claims |
| AstraZenecaSymbicort | $44 | $3,36311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $27 | $1,97954 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Denver
- Mia ScottDenver$993K
- Ethan LazarusDenver$688K
- Judith ShlayDenver$264K
- Mark DeutchmanDenver$258K
- Johnny ShenDenver$182K
- Flory KreutterDenver$118K
- Nathaniel MooreDenver$21K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.